Fullerene Derivatives for Tumor Treatment: Mechanisms and Application.

cellular immunity fullerene derivatives metastasis inhibition photodynamic treatment tumor treatment tumor vasculature

Journal

International journal of nanomedicine
ISSN: 1178-2013
Titre abrégé: Int J Nanomedicine
Pays: New Zealand
ID NLM: 101263847

Informations de publication

Date de publication:
2024
Historique:
received: 02 05 2024
accepted: 28 08 2024
medline: 30 9 2024
pubmed: 30 9 2024
entrez: 30 9 2024
Statut: epublish

Résumé

Fullerenes hold tremendous potential as alternatives to conventional chemotherapy or radiotherapy for tumor treatment due to their abilities to photodynamically kill tumor cells, destroy the tumor vasculature, inhibit tumor metastasis and activate anti-tumor immune responses, while protecting normal tissue through antioxidative effects. The symmetrical hollow molecular structures of fullerenes with abundant C=C bonds allow versatile chemical modification with diverse functional groups, metal clusters and biomacromolecules to synthesize a wide range of fullerene derivatives with increased water solubility, improved biocompatibility, enhanced photodynamic properties and stronger targeting abilities. This review introduces the anti-tumor mechanisms of fullerenes and summarizes the most recent works on the functionalization of fullerenes and the application of fullerene derivatives in tumor treatment. This review aims to serve as a valuable reference for further development and clinical application of anti-tumor fullerene derivatives.

Identifiants

pubmed: 39345909
doi: 10.2147/IJN.S476601
pii: 476601
pmc: PMC11430870
doi:

Substances chimiques

Fullerenes 0
Antineoplastic Agents 0
Photosensitizing Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9771-9797

Informations de copyright

© 2024 Hou et al.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest in this work.

Auteurs

Wenjia Hou (W)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.
State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, 200438, People's Republic of China.

Lan Shen (L)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.

Yimin Zhu (Y)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.

Xuanjia Wang (X)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.

Tianyu Du (T)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.

Fang Yang (F)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.

Yabin Zhu (Y)

Health Science Center, Ningbo University, Ningbo, 315211, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH